Literature DB >> 5676405

Effect of interferon, polyacrylin acid, and polymethacrylic acid on tail lesions on mice infected with vaccinia virus.

E De Clercq, P De Somer.   

Abstract

Intravenous inoculation of mice with vaccinia virus produced characteristic lesions of the tail surface which were suppressed by intraperitoneal administration of interferon and polyacrylic acid (PAA). Polymethacrylic acid (PMAA) stimulated the formation of vaccinia virus lesions. For full activity, both interferon and PAA must be given prior to infection. PAA was still significantly effective at small dose levels (3 mg/kg) and achieved protection for at least 4 weeks. Protection increased with increasing molecular weight of the polymer. The mode of action of PAA is discussed.

Entities:  

Mesh:

Substances:

Year:  1968        PMID: 5676405      PMCID: PMC547647          DOI: 10.1128/am.16.9.1314-1319.1968

Source DB:  PubMed          Journal:  Appl Microbiol        ISSN: 0003-6919


  6 in total

1.  Response of mice to ectromelia and vaccinia viruses.

Authors:  B A BRIODY
Journal:  Bacteriol Rev       Date:  1959-06

2.  Evaluation of antiviral compounds by suppression of tail lesions in vaccinia-infected mice.

Authors:  J J Boyle; R F Haff; R C Stewart
Journal:  Antimicrob Agents Chemother (Bethesda)       Date:  1966

3.  Induction of circulating interferon by synthetic anionic polymers of known composition.

Authors:  T C Merigan
Journal:  Nature       Date:  1967-04-22       Impact factor: 49.962

4.  Antiviral activity of polyacrylic and polymethacrylic acids. II. Mode of action in vivo.

Authors:  P De Somer; E De Clercq; A Billiau; E Schonne; M Claesen
Journal:  J Virol       Date:  1968-09       Impact factor: 5.103

5.  Antiviral activity of polyacrylic and polymethacrylic acids. I. Mode of action in vitro.

Authors:  P De Somer; E De Clercq; A Billiau; E Schonne; M Claesen
Journal:  J Virol       Date:  1968-09       Impact factor: 5.103

6.  Interferon-like virus-inhibitor induced in human leukocytes by phytohemagglutinin.

Authors:  E F Wheelock
Journal:  Science       Date:  1965-07-16       Impact factor: 47.728

  6 in total
  19 in total

1.  The immune response to infection with vaccinia virus in mice. I. Infection and the production of antibody neutralizing cell-associated and cell-free virus.

Authors:  L M Hutt
Journal:  J Hyg (Lond)       Date:  1975-06

2.  Mechanism of resistance to virus challenge in mice infected with Brucella abortus.

Authors:  J J Muyembe; A Billiau; P De Somer
Journal:  Arch Gesamte Virusforsch       Date:  1972

3.  Interferon in experimental viral infections in mice: tissue interferon levels resulting from the virus infection and from exogenous interferon therapy.

Authors:  H Heremans; A Billiau; P De Somer
Journal:  Infect Immun       Date:  1980-11       Impact factor: 3.441

Review 4.  Orthopoxvirus targets for the development of antiviral therapies.

Authors:  Mark N Prichard; Earl R Kern
Journal:  Curr Drug Targets Infect Disord       Date:  2005-03

Review 5.  Vaccinia virus inhibitors as a paradigm for the chemotherapy of poxvirus infections.

Authors:  E De Clercq
Journal:  Clin Microbiol Rev       Date:  2001-04       Impact factor: 26.132

6.  Interferon-inducing polycarboxylates: mechanism of protection against vaccinia virus infection in mice.

Authors:  A Billiau; J J Muyembe; P De Somer
Journal:  Infect Immun       Date:  1972-06       Impact factor: 3.441

7.  Efficacy of multiple- or single-dose cidofovir against vaccinia and cowpox virus infections in mice.

Authors:  Debra C Quenelle; Deborah J Collins; Earl R Kern
Journal:  Antimicrob Agents Chemother       Date:  2003-10       Impact factor: 5.191

8.  Observations of cattle, goats and pigs after administration of synthetic interferon inducers and subsequent exposure to foot and mouth disease virus.

Authors:  J W McVicar; J Y Richmond; C H Campbell; L D Hamilton
Journal:  Can J Comp Med       Date:  1973-10

9.  Protection of rabbits against local vaccinia virus infection by Brucella abortus and polyacrylic acid in the absence of systemic interferon production.

Authors:  E De Clercq; P De Somer
Journal:  Infect Immun       Date:  1973-10       Impact factor: 3.441

10.  Antiviral activity of carbopol, a cross-linked polycarboxylate.

Authors:  E de Clercq; M Luczak
Journal:  Arch Virol       Date:  1976       Impact factor: 2.574

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.